Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

INARCTICA reported for 2023 by IFRS

3/18/24 AQUA

MTS launches new billing system

3/18/24 MTSS

Rusal started using aluminum quotations on the Shanghai Exchange

3/18/24 RUAL

Ministry of Transport proposed to introduce parking lots for electric scooters

3/18/24 WUSH

Nornickel and partners to evaluate Cuba's nickel deposits

3/18/24 GMKN

TRK reported for 2023 by RAS

3/15/24 TORS

Rusal reported for 2023 by RAS

3/15/24 RUAL

EL5-Energo reported for 2023 by RAS

3/15/24 ELFV

Yuzhuralnickel reported for 2023 by RAS

3/15/24 UNKL

On brainbox.VC appeared CyberTsekh

3/15/24 OTCI